BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3120270)

  • 1. Selegiline in narcolepsy.
    Roselaar SE; Langdon N; Lock CB; Jenner P; Parkes JD
    Sleep; 1987 Oct; 10(5):491-5. PubMed ID: 3120270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine, mazindol, and fencamfamin in narcolepsy.
    Shindler J; Schachter M; Brincat S; Parkes JD
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1167-70. PubMed ID: 2859077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical effects of L-deprenyl in atypical depressives.
    Liebowitz MR; Karoum F; Quitkin FM; Davies SO; Schwartz D; Levitt M; Linnoila M
    Biol Psychiatry; 1985 May; 20(5):558-65. PubMed ID: 3921065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mazindol in the treatment of narcolepsy.
    Parkes JD; Schachter M
    Acta Neurol Scand; 1979 Oct; 60(4):250-4. PubMed ID: 525256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
    J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selegiline in the treatment of narcolepsy.
    Hublin C; Partinen M; Heinonen EH; Puukka P; Salmi T
    Neurology; 1994 Nov; 44(11):2095-101. PubMed ID: 7969965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of mazindol on narcolepsy.
    Iijima S; Sugita Y; Teshima Y; Hishikawa Y
    Sleep; 1986; 9(1 Pt 2):265-8. PubMed ID: 3704452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprenyl in narcolepsy.
    Schachter M; Price PA; Perkes JD
    Lancet; 1979 Apr; 1(8120):831-2. PubMed ID: 86082
    [No Abstract]   [Full Text] [Related]  

  • 9. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.
    Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I
    Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.
    Parkes JD; Fenton GW
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):1076-81. PubMed ID: 4359162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
    Shelton J; Nishino S; Vaught J; Dement WC; Mignot E
    Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties.
    Elsworth JD; Sandler M; Lees AJ; Ward C; Stern GM
    J Neural Transm; 1982; 54(1-2):105-10. PubMed ID: 6809891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REM changes in narcolepsy with selegiline.
    Reinish LW; MacFarlane JG; Sandor P; Shapiro CM
    Sleep; 1995 Jun; 18(5):362-7. PubMed ID: 7676170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial.
    Elwes RD; Crewes H; Chesterman LP; Summers B; Jenner P; Binnie CD; Parkes JD
    Lancet; 1989 Nov; 2(8671):1067-9. PubMed ID: 2572797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Narcolepsy].
    Lange KW
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1244-50. PubMed ID: 2201510
    [No Abstract]   [Full Text] [Related]  

  • 16. Current controversies in the use of selegiline hydrochloride.
    Lees AJ
    J Neural Transm Suppl; 1987; 25():157-62. PubMed ID: 3123602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.
    Schachter M; Marsden CD; Parkes JD; Jenner P; Testa B
    J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):1016-21. PubMed ID: 6777463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.
    Schulz R; Antonin KH; Hoffmann E; Jedrychowski M; Nilsson E; Schick C; Bieck PR
    Clin Pharmacol Ther; 1989 Nov; 46(5):528-36. PubMed ID: 2510962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
    Scharf MB; Brown D; Woods M; Brown L; Hirschowitz J
    J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of extra-puerperal galactorrhea with the MAO-B inhibitor selegiline].
    Sas M; Godó G; Koleszár G
    Orv Hetil; 1986 Jun; 127(25):1507-8, 1511. PubMed ID: 3088511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.